This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) provides results from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Over half of participants tested positive for hepatitis C antibodies and 78% of those engaging with further assessment assessment in secondary care had chronic hepatitis C and were hepatitis C RNA positive.
Related resources
-
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 1)
England, Greater London Reports & Research PDF -
United Kingdom drug situation: Focal Point annual report 2017
The UK Focal Point on Drugs' (part of Public Health England) annual report on the United Kingdom drug situation, providing updates for 2017. The report contains details of hepatitis C prevalence and incidence rates among injecting drug users, levels of testing, diagnosis and treatment for hepatitis C and prevention efforts by UK governments.UK Reports & Research PDF -
Business case template: ITTREAT (Integrated community-based Test – stage – TREAT)
Following a successful 4-year project evaluation in Brighton, the ITTREAT team have produced a commissioning business case template based on their project, intended for use to secure funding for a specialist hepatitis C nurse and develop an integrated community-based hepatitis C service to engage PWID. The template is available for download in word and is designed to be locally amended.
UK, South East Case study, Tools & Templates, Strategy & Planning MS Word -
Good practice case study: ITTREAT (Integrated community-based Test – stage – TREAT)
This HCV Action good practice case study summarises a 4-year Integrated Test-stage and TREAT (ITTREAT) community project in Brighton, where a specialist hepatitis nurse was appointed to lead a ‘one-stop’ holistic hepatitis C service - including testing, assessment of liver scarring, education and treatment - within a community-based substance misuse service.
UK, South East Case study PDF -
Hepatitis B/C in the countries of the EU/ EEA: a systematic review of the prevalence among at-risk groups
This 2018 study provides estimates of hepatitis C (and hepatitis B) prevalence among people in prison, men who have sex with men (MSM) and people who inject drugs (PWID) in countries which are member states of the European Union and European Economic Area. This article has been republished by HCV Action under the terms of the Creative Commons license: http://creativecommons.org/licenses/by/4.0/UK, Rest of World Reports & Research PDF